Navigation Links
Rodobo International, Inc. Files Fiscal Year 2008 SEC Form 10-K
Date:1/13/2009

HARBIN, China, Jan. 13 /PRNewswire-Asia-FirstCall/ -- Rodobo International, Inc. (OTC Bulletin Board: RDBO) filed its Annual Report on Form 10-K for its fiscal year ended September 30, 2008 today. Key highlights from the financial results of the fiscal year ended September 30, 2008 include:

    -- Revenue increased 72.7% year over year to $22.1 million from
       $12.8 million in fiscal year 2007.
    -- Gross profit increased 67.7% year over year to $10.4 million from
       $6.2 million in fiscal year 2007.
    -- Net income increased 111.5% year over year to $5.5 million from
       $2.6 million in fiscal year 2007; comprehensive income increased
       129.6% year over year to $6.2 million from $2.7 million in fiscal
       year 2007.

Mr. Yanbin Wang, Chief Executive Officer of Rodobo International, stated, "We are happy to report strong 2008 results with our shareholders today. We posted strong top line growth of 72.7% as well as healthy gross profit and net income growth, which indicated our further market penetration and increased popularity of our products among customers. We have not been implicated in the recent melamine contamination problems. We will continue to leverage our superior quality control and further strengthen our market position as consumers seek out quality products in the wake of the recent wide-spread melamine contamination scandal."

Revenue for the fiscal year ended September 30, 2008 was primarily attributable to a 23.0% increase in average selling price and sales volume growth driven by the Company's continuous efforts on developing a distribution network and enhancing the ability to expand the customer base.

Due to increased material costs and labor costs, the cost of goods sold increased by 77.3%, greater than the 72.7% increase in sales. Therefore, the overall gross margin slightly decreased from 48.4% in 2007 to 47.1% in 2008.


'/>"/>

SOURCE Rodobo International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
2. Arrow International, Inc. Invites You to Join Its 2007 Annual Meeting of Shareholders on the Web
3. Natural Alternatives International, Inc. Announces Late Filing of its Annual Report on Form 10-K, Revenue for Fiscal 2007 and Guidance on First Quarter of Fiscal 2008
4. Cryo-Cell International, Inc. Reports Third Quarter 2007 Results
5. TenderCare International, Inc. Announces Signing of Merger Agreement with the Hain Celestial Group for All Outstanding Shares of TenderCare Stock
6. Chindex International, Inc. Announces Results for the Quarter and Six Months Ended September 30, 2007
7. DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results
8. Chindex International, Inc. Announces Transfer to NASDAQ Global Market
9. MINRAD International, Inc. Announces Appointment of Charles R. Trego, Jr. to CFO & EVP
10. Synutra International, Inc. Amends August 2005 Current Report on Form 8-K and Annual Report on Form 10-K for the Fiscal Year Ended March 31, 2007
11. Natural Alternatives International, Inc. Announces Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)AVIVA today announced the launch of International Solutions, an innovative new international private medical insurance plan which follows the acclaimed modular design of its UK equivalent. In addition
(Date:12/4/2009)PALO ALTO, Calif., Dec. 4 Varian Medical Systems (NYSE: VAR ) announced today that its Board of Directors has set the regular 2010 Annual Meeting of Stockholders for February 11, 2010 with a record
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
(Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th
(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w
Breaking Medicine News(10 mins):Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2
...ck bowel; warnings not mandated on packages, study...ws) -- Parents need to be better warned about pote...wing toys with magnets before shopping for present...gestive tract, the need for surgery, and even deat...
...rescription Prenatal Vitamins , , PrimaCare O...ensive once-daily prescription prenatal vitamin in...nd EPA , , ST. LOUIS, Dec. 17 KV Pharmaceuti...al vitamins - has enhanced the formulation of one ...
...od of use to treat mildly infected diabetic foot u... double-blinded multi-center clinical trials of pe...ARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) an...ild diabetic foot infection were published in the ...
...swire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ... the global life sciences markets, today reported ...ear-end results for the period ended October 31, 2...Services goodwill that was previously announced on...
...SynCare, LLC, today announced that,Ian Duncan has ...-renowned,author and expert in the field of diseas...ings a wealth of experience and knowledge to the S..."Ian is a pioneer in the use of,risk-adjustment an...
... mPay Gateway, a Minneapolis, MN company specia... today that a Minneapolis-area primary care clinic...ceivable by more than 50% after successfully imple...amatic A/R reduction within 12 weeks. , ...
Other Medicine News:Health News:Magnets in Kids' Toys Pose Broad Dangers 2Health News:KV Pharmaceutical Launches Enhanced Formulation of PrimaCare ONE(R) 2Health News:KV Pharmaceutical Launches Enhanced Formulation of PrimaCare ONE(R) 3Health News:KV Pharmaceutical Launches Enhanced Formulation of PrimaCare ONE(R) 4Health News:KV Pharmaceutical Launches Enhanced Formulation of PrimaCare ONE(R) 5Health News:Pexiganan Phase 3 Clinical Trials Results Published in December Issue of CID 2Health News:Pexiganan Phase 3 Clinical Trials Results Published in December Issue of CID 3Health News:Pexiganan Phase 3 Clinical Trials Results Published in December Issue of CID 4Health News:MDS Reports Preliminary Fourth Quarter 2008 Results 2Health News:MDS Reports Preliminary Fourth Quarter 2008 Results 3Health News:MDS Reports Preliminary Fourth Quarter 2008 Results 4Health News:MDS Reports Preliminary Fourth Quarter 2008 Results 5Health News:MDS Reports Preliminary Fourth Quarter 2008 Results 6Health News:MDS Reports Preliminary Fourth Quarter 2008 Results 7Health News:MDS Reports Preliminary Fourth Quarter 2008 Results 8Health News:MDS Reports Preliminary Fourth Quarter 2008 Results 9Health News:MDS Reports Preliminary Fourth Quarter 2008 Results 10Health News:MDS Reports Preliminary Fourth Quarter 2008 Results 11Health News:MDS Reports Preliminary Fourth Quarter 2008 Results 12Health News:MDS Reports Preliminary Fourth Quarter 2008 Results 13Health News:MDS Reports Preliminary Fourth Quarter 2008 Results 14Health News:MDS Reports Preliminary Fourth Quarter 2008 Results 15Health News:MDS Reports Preliminary Fourth Quarter 2008 Results 16Health News:MDS Reports Preliminary Fourth Quarter 2008 Results 17Health News:MDS Reports Preliminary Fourth Quarter 2008 Results 18Health News:MDS Reports Preliminary Fourth Quarter 2008 Results 19Health News:MDS Reports Preliminary Fourth Quarter 2008 Results 20Health News:MDS Reports Preliminary Fourth Quarter 2008 Results 21Health News:MDS Reports Preliminary Fourth Quarter 2008 Results 22Health News:MDS Reports Preliminary Fourth Quarter 2008 Results 23Health News:MDS Reports Preliminary Fourth Quarter 2008 Results 24Health News:MDS Reports Preliminary Fourth Quarter 2008 Results 25Health News:MDS Reports Preliminary Fourth Quarter 2008 Results 26Health News:MDS Reports Preliminary Fourth Quarter 2008 Results 27Health News:MDS Reports Preliminary Fourth Quarter 2008 Results 28
(Date:12/4/2009)OMAHA, Neb., Dec. 4 Amber Pharmacy announced today that it received accreditation by the Accreditation Commission for Health Care, Inc. (ACHC) for specialized pharmacy services. For nearly 15 years,
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today the presentation of new d
(Date:12/4/2009)SAN DIEGO, Calif., Dec. 4 Suneva Medical, a privately-held aesthetic medical device company, today announced the appointment of Philip Ranker as Vice President and Chief Financial Officer. In this r
Breaking Medicine Technology:Amber Pharmacy Earns Accreditation From ACHC 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4New technique can help diagnose mesothelioma 55087 1New technique can help diagnose mesothelioma 55087 2Business Association in Denver Invites Award winning Author of ColorAlchemy to Provide Motivation to Energize Performance and Stimulate Success Using 55085 1Business Association in Denver Invites Award winning Author of ColorAlchemy to Provide Motivation to Energize Performance and Stimulate Success Using 55085 2Business Association in Denver Invites Award winning Author of ColorAlchemy to Provide Motivation to Energize Performance and Stimulate Success Using 55085 3Business Association in Denver Invites Award winning Author of ColorAlchemy to Provide Motivation to Energize Performance and Stimulate Success Using 55085 4Fragile period of childhood brain development could underlie epilepsy 55082 1Fragile period of childhood brain development could underlie epilepsy 55082 2
...Utilized as an Adjuvant and Play Key Role in the,T...., March 20, 2007 /PRNewswire-FirstCall/ --,Immune...,BioSciences Holdings, Inc. , announced today that...nalog, Homspera, suggests that the,compound has po...,adjuvant. Studies performed in animal models of i...
...ronger FDA says drug review programs need more,mon...ire/ -- A new,estimate by the Alzheimer,s Associat...e living with Alzheimer,s disease -- a 10,percent ...ould more,than triple in the coming decades unless...bilitating illness. , The new numbers re-emphasize...
Other Medicine Technology:ImmuneRegen BioSciences Announces Promising Data on Homspera,Suggesting Potential as a Co-Therapeutic Agent 2ImmuneRegen BioSciences Announces Promising Data on Homspera,Suggesting Potential as a Co-Therapeutic Agent 3ImmuneRegen BioSciences Announces Promising Data on Homspera,Suggesting Potential as a Co-Therapeutic Agent 4Alzheimer's Growth Shows Need for Increased FDA Funding 2Alzheimer's Growth Shows Need for Increased FDA Funding 3
Straight Tissue Forceps
Sanders-Castroviejo Suturing Forceps
Storz Bonn Suturing Forceps
Berens Curved Suturing Forceps
Medicine Products: